Pfizer breaks ground on new biologics clinical manufacturing facility
Pfizer broke ground on its new Andover, MA-based biologics clinical manufacturing facility this week, which will feature single-use and disposable technologies.
The company will invest more than $200m in development of the 175,000 sq. ft. facility, which is expected to be operational by January 2019.
According to Pfizer, the new clinical manufacturing facility was designed with five independent manufacturing suites.
The facility will feature single-use bioreactors and disposable process technologies and will be fully enabled to support next generation manufacturing.
The Andover campus currently includes seven buildings housing laboratories, clinical and commercial manufacturing suites, and other support areas.
The campus also features a multiproduct manufacturing facility.
As part of the new investment, Pfizer will hire approximately 75 new employees to support clinical manufacturing.
